Search all trials

Find therapies in clinical trials near you – page 5

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Asthma

Not recruiting

Registered drugNo placebo

Study on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Salbutamol

Contact Research Centre

Conjunctivitis allergic+1

Not recruiting

Registered drug

Study on the Effectiveness of PURETHAL Mites for Adults with Moderate to Severe Allergic Rhinitis or Rhinoconjunctivitis Due to House Dust Mite Allergy

Registered drug

Germany

Participants:18–64 years
Substances:Aluminium Hydroxide

Contact Research Centre

Crohn's disease

Not recruiting

Investigational

Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Tulisokibart

Contact Research Centre

Conjunctivitis allergic+1

Not recruiting

Registered drug

Dose‑finding trial of a mannan‑conjugated Phleum pratense/Dactylis glomerata allergoid vaccine in patients with grass‑pollen allergic rhinitis or rhinoconjunctivitis

Registered drug

Germany

Participants:18–64 years
Substances:Bilastine

Contact Research Centre

Bladder transitional cell carcinoma

Not recruiting

Registered drug

Study on the Effectiveness of Durvalumab and BCG in Treating High-Risk, Non-Muscle Invasive Bladder Cancer in Patients New to BCG Treatment

Registered drug

Germany

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Durvalumab

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effectiveness and Safety of SAR441566 for Adults with Moderate-to-Severe Ulcerative Colitis

Investigational

Germany

Participants:18–64 years · 65+ years

Contact Research Centre

Hormone-refractory prostate cancer

Not recruiting

Registered drugNo placebo

Study Comparing BMS-986365 with Other Treatments for Patients with Metastatic Castration-resistant Prostate Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Abiraterone

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study on Adding Isatuximab to Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Glioblastoma

Not recruiting

InvestigationalNo placebo

Study on the Effectiveness and Safety of a Vaccine with Dendritic Cells for Patients with Newly Diagnosed Glioblastoma

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Autologous Mature Dendritic Cells Loaded With Autologous Tumor Lysate

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effects of Tamuzimod in Patients with Moderate to Severe Ulcerative Colitis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Tamuzimod Acetate

Contact Research Centre

Prostate cancer

Not recruiting

InvestigationalNo placebo

Study of Apalutamide for Patients with High-Risk Prostate Cancer After Prostate Removal

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Apalutamide

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Comparison of intravenous versus subcutaneous isatuximab with lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma patients eligible for transplant

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Find therapies in clinical trials near you – page 5

77 trials match your criteria

Asthma

Study on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma

Conjunctivitis allergic+1

Study on the Effectiveness of PURETHAL Mites for Adults with Moderate to Severe Allergic Rhinitis or Rhinoconjunctivitis Due to House Dust Mite Allergy

Crohn's disease

Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults

Conjunctivitis allergic+1

Dose‑finding trial of a mannan‑conjugated Phleum pratense/Dactylis glomerata allergoid vaccine in patients with grass‑pollen allergic rhinitis or rhinoconjunctivitis

Bladder transitional cell carcinoma

Study on the Effectiveness of Durvalumab and BCG in Treating High-Risk, Non-Muscle Invasive Bladder Cancer in Patients New to BCG Treatment

Colitis ulcerative

Study on the Effectiveness and Safety of SAR441566 for Adults with Moderate-to-Severe Ulcerative Colitis

Hormone-refractory prostate cancer

Study Comparing BMS-986365 with Other Treatments for Patients with Metastatic Castration-resistant Prostate Cancer

Plasma cell myeloma

Study on Adding Isatuximab to Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Glioblastoma

Study on the Effectiveness and Safety of a Vaccine with Dendritic Cells for Patients with Newly Diagnosed Glioblastoma

Colitis ulcerative

Study on the Effects of Tamuzimod in Patients with Moderate to Severe Ulcerative Colitis

Prostate cancer

Study of Apalutamide for Patients with High-Risk Prostate Cancer After Prostate Removal

Plasma cell myeloma

Comparison of intravenous versus subcutaneous isatuximab with lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma patients eligible for transplant

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.